Phase III randomized clinical trial of BV-4051, an Ayurvedic polyherbal formulation in moderate SARS-CoV-2 infections and its impact on inflammatory biomarkers
Chitre et al., Phytotherapy Research, doi:10.1002/ptr.7683
https://c19early.org/chitre.html